GW Pharmaceuticals PLC- ADR GWPH 2.24% has dipped below $85 for the first time since June and is now on the brink of a technical breakdown. After a huge jump back in March following positive Phase 3 data on Epidiolex, the stock has traded in the bullish channel included on the chart below.

After failing in both June and July to break above $98, however, GW is now up against the bottom of the channel. The stock found support at around the $83 level back in June. But below $83, there is very little technical support down to $70, which represents the stocks post-news low.

GW’s stock has demonstrated extreme volatility in the past two years, but has made little overall progress. Since the beginning of August 2014, the stock climbed as much as 40 percent within a year. By March 2016, prior to the Phase 3 Epidiolex data, the stock had plummeted…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!